Sunsino Venture Group

Sunsino Venture Group is a Taiwan-based investment firm with a long history in venture and growth investing across technology, manufacturing, life sciences, and adjacent sectors, with strong ties into the Taiwanese and broader Asian innovation ecosystem. The firm operates with a generalist mandate that includes healthcare and life sciences exposure, and check sizes typically span from low single-digit millions at early growth stages to larger commitments in later rounds, depending on the specific fund and strategy. Healthcare AI founders should consider Sunsino primarily if the company has clear ambitions in Asian markets or strategic relationships with Taiwanese manufacturing, supply chain, or distribution partners that the firm’s network can unlock. The natural fit is a healthcare company with credible commercial traction, a defined regulatory pathway, and either a defined Asian market opportunity or a manufacturing and supply-chain dimension that benefits from Taiwanese partnerships. Pure consumer wellness or generalist software without an Asian angle will fit less naturally. Founders should expect a more deliberate, committee-style decision process and a strategic-flavored partnership orientation. The best entry path is a warm introduction from a portfolio CEO, a Taiwanese operator, an Asia-Pacific banker, or a strategic advisor with relationships into the firm. Direct outreach via LinkedIn to the investment team is also a credible path, ideally framed around the specific Asian opportunity and supported by a clear executive summary, current pipeline data, and a specific use of proceeds tied to expansion in the region.